The global psoriasis biosimilars market is set to experience robust growth, with market value projected to rise from USD 9,228.6 million in 2024 to an impressive USD 26,679.9 million by 2034, registering a CAGR of 11.2% during the forecast period. In 2023, the market generated USD 8,412.6 million in revenue, underscoring its accelerating momentum. Key …